Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Versant Ventures
Biotech
Merck KGaA pledges $50M to new biotech with eye to acquisition
The cash will power Saturnus Bio's research into genetic heart diseases, with Merck KGaA holding the exclusive right to buy the NewCo down the line.
Darren Incorvaia
Jun 23, 2026 10:16am
J&J makes $1B bet on emerging DAC space by netting Firefly Bio
Jun 8, 2026 10:05am
Versant's Dayra dawns with $50M Biogen pact
Nov 24, 2025 10:28am
After 'complete standstill,' biotech market reaches new normal
Aug 20, 2025 11:04am
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Apr 25, 2025 8:30am
Versant unveils new autoimmune biotech with $100M fundraise
Apr 24, 2025 8:00am
